Emergent BioSolutions to face congressional probe over contracts to manufacture COVID-19 vaccines


Maloney and Clyburn requested the company’s CEO Robert Kramer and Executive Chairman Fuad El-Hibri to testify at a hearing on May 19.  


Have a story you want USA Herald to cover? Submit a tip here and if we think it’s newsworthy, we’ll follow up on it.

Signup for the USA Herald exclusive Newsletter

Want to contribute a story? We also accept article submissions — check out our writer’s guidelines here.